99 related articles for article (PubMed ID: 8158034)
1. Apparent selection against transmission of zidovudine-resistant human immunodeficiency virus type 1 variants.
Wahlberg J; Fiore J; Angarano G; Uhlén M; Albert J
J Infect Dis; 1994 Mar; 169(3):611-4. PubMed ID: 8158034
[TBL] [Abstract][Full Text] [Related]
2. Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance.
Conlon CP; Klenerman P; Edwards A; Larder BA; Phillips RE
J Infect Dis; 1994 Feb; 169(2):411-5. PubMed ID: 7508970
[TBL] [Abstract][Full Text] [Related]
3. Characterization of HIV isolates arising after prolonged zidovudine therapy.
Mayers DL; McCutchan FE; Sanders-Buell EE; Merritt LI; Dilworth S; Fowler AK; Marks CA; Ruiz NM; Richman DD; Roberts CR
J Acquir Immune Defic Syndr (1988); 1992; 5(8):749-59. PubMed ID: 1381438
[TBL] [Abstract][Full Text] [Related]
4. Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group.
Imrie A; Beveridge A; Genn W; Vizzard J; Cooper DA
J Infect Dis; 1997 Jun; 175(6):1502-6. PubMed ID: 9180194
[TBL] [Abstract][Full Text] [Related]
5. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus.
de Ronde A; van Dooren M; van Der Hoek L; Bouwhuis D; de Rooij E; van Gemen B; de Boer R; Goudsmit J
J Virol; 2001 Jan; 75(2):595-602. PubMed ID: 11134272
[TBL] [Abstract][Full Text] [Related]
6. Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation.
Fitzgibbon JE; Gaur S; Frenkel LD; Laraque F; Edlin BR; Dubin DT
N Engl J Med; 1993 Dec; 329(25):1835-41. PubMed ID: 8247034
[TBL] [Abstract][Full Text] [Related]
7. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.
Erice A; Mayers DL; Strike DG; Sannerud KJ; McCutchan FE; Henry K; Balfour HH
N Engl J Med; 1993 Apr; 328(16):1163-5. PubMed ID: 8455683
[No Abstract] [Full Text] [Related]
8. Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates.
Shafer RW; Kozal MJ; Katzenstein DA; Lipil WH; Johnstone IF; Merigan TC
J Virol Methods; 1993 Mar; 41(3):297-310. PubMed ID: 8097199
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitor.
Staszewski S; Massari FE; Kober A; Göhler R; Durr S; Anderson KW; Schneider CL; Waterbury JA; Bakshi KK; Taylor VI
J Infect Dis; 1995 May; 171(5):1159-65. PubMed ID: 7538547
[TBL] [Abstract][Full Text] [Related]
10. Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus.
Veenstra J; Schuurman R; Cornelissen M; van't Wout AB; Boucher CA; Schuitemaker H; Goudsmit J; Coutinho RA
Clin Infect Dis; 1995 Sep; 21(3):556-60. PubMed ID: 8527543
[TBL] [Abstract][Full Text] [Related]
11. Use of self-sustained sequence replication amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus.
Gingeras TR; Prodanovich P; Latimer T; Guatelli JC; Richman DD; Barringer KJ
J Infect Dis; 1991 Dec; 164(6):1066-74. PubMed ID: 1955709
[TBL] [Abstract][Full Text] [Related]
12. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1.
Frenkel LM; Wagner LE; Demeter LM; Dewhurst S; Coombs RW; Murante BL; Reichman RC
Clin Infect Dis; 1995 May; 20(5):1321-6. PubMed ID: 7620018
[TBL] [Abstract][Full Text] [Related]
13. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
Sheehy N; Desselberger U
J Gen Virol; 1993 Feb; 74 ( Pt 2)():223-8. PubMed ID: 7679140
[TBL] [Abstract][Full Text] [Related]
15. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
Kuritzkes DR; Sevin A; Young B; Bakhtiari M; Wu H; St Clair M; Connick E; Landay A; Spritzler J; Kessler H; Lederman MM
J Infect Dis; 2000 Feb; 181(2):491-7. PubMed ID: 10669331
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction.
Richman DD; Guatelli JC; Grimes J; Tsiatis A; Gingeras T
J Infect Dis; 1991 Dec; 164(6):1075-81. PubMed ID: 1720152
[TBL] [Abstract][Full Text] [Related]
17. Transmission of zidovudine-resistant HIV-1.
Sönnerburg A; Johansson B; Ayehunie S; Julander I
AIDS; 1993 Dec; 7(12):1684-5. PubMed ID: 8286086
[No Abstract] [Full Text] [Related]
18. Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy.
Kojima E; Shirasaka T; Anderson BD; Chokekijchai S; Steinberg SM; Broder S; Yarchoan R; Mitsuya H
J Infect Dis; 1995 May; 171(5):1152-8. PubMed ID: 7751690
[TBL] [Abstract][Full Text] [Related]
19. Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.
Masquelier B; Pellegrin I; Ruffault A; Ragnaud JM; Morlat P; Michelet C; Doignon F; Biteau N; Fleury HJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):330-4. PubMed ID: 7533640
[TBL] [Abstract][Full Text] [Related]
20. Transmission of zidovudine-resistant HIV-1 through heterosexual contacts.
Angarano G; Monno L; Appice A; Giannelli A; Romanelli C; Fico C; Pastore G
AIDS; 1994 Jul; 8(7):1013-4. PubMed ID: 7524541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
